The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples